Introduction
The Halene Laboratory focuses on the study of myeloid malignancies and hematopoiesis. In particular we seek to understand the role of mutations in splicing factors, present in nearly 50% of patient with Myelodysplasia (MDS) and Acute Myeloid Leukemia (AML). In addition, we seek to establish a “co-clinical” model for MDS and AML with the goal to facilitate the translation of improved, less toxic, and more efficient treatments for MDS and AML into the clinic.
Twitter Feed
@Halene_lab Retweeted @YaleCancerCongratulations to @Dr_AmerZeidan for being highlighted as a “trailblazing investigator” by @LLSusa 2020 for his research efforts and advances in chronic myeloid leukemia! #CML @SmilowCancer @YaleMed @YNHH @YaleHematology #leukemia #BloodDisorders https://t.co/FeFwBFq5TcA MONTH AGO
@Halene_lab Retweeted @YaleCancer"Our goal is to contribute to the development of novel treatments to treat #blooddisorders. Our dedication to the eradication of these cancers is unwavering!"— Dr. Stephanie Halene @HaleneLab recognizing #WorldCancerDay. @SmilowCancer @YaleMed @YNHH @YaleHematology https://t.co/Dv9syh4JwdA MONTH AGO
@Halene_lab Retweeted @YaleCCEHThis month's CCEH Meet-the-Expert series features Chief of @YaleHematology Dr. Stephanie Halene (@Halene_lab)! Her talk about humanized mouse models for the study of #hematopoiesis is Thursday, Feb 3, at 3pm ET.
https://t.co/yn6CVeWMc7A MONTH AGO
Principal Investigator
Stephanie Halene, MD, PhD
Associate Professor of Medicine (Hematology)
Contact Information
- Office
- Fax
- Appt